Atlas Trials

A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients

Clinical trial NCT01228734 · COMPLETED

Trial details

NCT number
NCT01228734
Sponsor
Merck KGaA, Darmstadt, Germany
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2010-09-09
Primary completion
2016-01-25
Enrollment
553

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.